Coverage policy updates

Policy changes Backwork has recorded, newest first. The most recent change on record is from October 14, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.

Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.

Recorded changes

83,427 on record

Recorded policy changes, newest first
Recorded	Payer	Policy	Change
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	GENETIC TESTING FOR FLT3, NPM1, CEBPA, IDH1 AND IDH2 VARIANTS IN ACUTE MYELOID LEUKEMIA (EFFECTIVE 09/01/2026)PayerPolicy · BCBSM-2210507-45B34DD021	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	GENETIC TESTING-ASSAYS OF GENETIC EXPRESSION IN TUMOR TISSUE AS A TECHNIQUE TO HELP GUIDE DECISION-MAKING IN PATIENTS WITH BREAST CANCERPayerPolicy · BCBSM-86868-3CD924DD66	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	MAGNETIC PELVIC FLOOR STIMULATION (I.E., NEOTONUS) AND MECHANOTHERAPY (I.E., FLYTE) FOR URINARY AND/OIR FECAL INCONTINENCE - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2206867	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	GERMLINE GENETIC TESTING FOR BRCA1, BRCA2, AND PALB2 FOR HEREDITARY BREAST/OVARIAN CANCER SYNDROME AND ASSOCIATED HIGH-RISK CANCERSPayerPolicy · BCBSM-2017522	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	PERCUTANEOUS ELECTRICAL NERVE FIELD STIMULATION (E.G., IB-STIM) FOR FUNCTIONAL GASTROINTESTINAL DISORDERS INCLUDING IBS - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2208626	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	MULTI-BIOMARKER DISEASE ACTIVITY (MBDA) AND TREATMENT RESPONSE LABORATORY TESTING (E.G., VECTRA DA, PRISMRA) FOR RHEUMATOID ARTHRITISPayerPolicy · BCBSM-2045974	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	NONINVASIVE MEASUREMENT OF CENTRAL BLOOD PRESSURE (E.G., SPHYGMOCOR SYSTEM, VICORDER PULSE WAVE VELOCITY, PHYSIOWAVE) - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2194061	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	GENETIC TESTING FOR CARDIAC ION CHANNELOPATHIES (E.G., CONGENITAL LONG QT SYNDROME, BRUGADA SYNDROME, ETC.) - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2196214	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	HANDHELD RADIOFREQUENCY SPECTROSCOPY FOR INTRAOPERATIVE ASSESSMENT OF SURGICAL MARGINS DURING BREAST-CONSERVING SURGERY (E.G., MARGINPROBE) - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2193811	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	DUAL ENERGY X-RAY ABSORPTIOMETRY (DXA) AND BIOELECTRICAL IMPEDANCE ANALYSIS (BIA) TO DETERMINE BODY COMPOSITION - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2193623	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	MULTIMARKER SERUM-BASED TESTING RELATED TO OVARIAN CANCER (E.G., OVA1, OVERA, OVAWATCH, GLYCOKNOW OVARIAN AND ROMA TESTING)PayerPolicy · BCBSM-2009436	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	INTENSITY-MODULATED RADIATION THERAPY (IMRT) AND IMAGE-GUIDED RADIATION THERAPY (IGRT) OF THE PROSTATE (EFFECTIVE 07/01/2026)PayerPolicy · BCBSM-2209367-D3D4CE1BF2	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	BONE MARROW TRANSPLANT - HEMATOPOIETIC CELL TRANSPLANTATION FOR EPITHELIAL AND SMALL CELL OVARIAN CANCER (EFFECTIVE 09/01/2026)PayerPolicy · BCBSM-2210520-A32040120C	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	IMPLANTABLE PERIPHERAL NERVE STIMULATION AND PERIPHERAL SUBCUTANEOUS FIELD STIMULATION DEVICES FOR THE TREATMENT OF CHRONIC PAIN - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2202080	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	PERCUTANEOUS ELECTRICAL NERVE STIMULATION (PENS) AND PERCUTANEOUS NEUROMODULATION THERAPY (PNT), AND RESTORATIVE NEUROSTIMULATION THERAPY (E.G., REACTIV8)PayerPolicy · BCBSM-82964	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	TRANSESOPHAGEAL ENDOSCOPIC THERAPIES FOR GASTROESOPHAGEAL REFLUX DISEASE (GERD) (TRANSORAL ICISIONLESS FUNDOPLICATION - TIF [ESOPHYX, MUSE, GERDX])PayerPolicy · BCBSM-77021	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	HANDHELD RADIOFREQUENCY SPECTROSCOPY AND COMPUTER-AIDED FLUORESCECE IMAGING DURING BREAST-CONSERVING SURGERY E.G. MARGINPROBE, LUMISYSTEM)PayerPolicy · BCBSM-2053099	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	INTENSITY MODULATED RADIATION THERAPY (IMRT) AND IMAGE GUIDED RADIATION THERAPY (IGRT): CENTRAL NERVOUS SYSTEM TUMORSPayerPolicy · BCBSM-2047282	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	MULTIMARKER SERUM TESTING RELATED TO OVARIAN CANCER (E.G., OVA1, OVERA, OVAWATCH AND ROMA TESTING) - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2193630	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	CONTRAST-ENHANCED COMPUTED TOMOGRAPHY ANGIOGRAPHY (CTA, CCTA, MDCT, MSCT) OF THE HEART AND/OR CORONARY ARTERIES - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2193017	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	STEERABLE URETOEROSCOPIC RENAL EVACUATION (SURE PROCEDURE) WITH VACCUUM-ASSISTED STONE REMOVAL SYSTEMS FOR KIDNEY STONE MANAGEMENTPayerPolicy · BCBSM-2203139	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	DIGITAL HEALTH TECHNOLOGIES: DIAGNOSTIC APPLICATIONS (BEHAVIORAL HEALTH DISORDERS INCLUDING AUTISM SPECTRUM DISORDER) - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2199977	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	GENETIC TESTING FOR MARFAN SYNDROME, EHLERS-DANLOS, THORACIC AORTIC ANEURYSMS AND DISSECTIONS, AND CONNECTIVE TISSUE RELATED DISORDERSPayerPolicy · BCBSM-2005615	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	PHRENIC NERVE STIMULATION AND DIAPHRAGM PACING (E.G., MARK IV, NEURX, DPS, AND RA/4) - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2197884	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	BCN ONLY: TELEMEDICINE (end date 04/30/2020) see joint policy Doc ID: 2121766PayerPolicy · BCBSM-2089117	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	TEMPORARILY IMPLANTED PROSTATIC STENTS FOR BENIGN PROSTATIC HYPERPLASIA (E.G., NITINOL DEVICE [ITIND], SPANNERTM) - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2195915	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	INTENSITY MODULATED RADIATION THERAPY (IMRT) AND IMAGE GUIDED RADIATION THERAPY (IGRT): CANCER OF THE HEAD AND NECK OR THYROIDPayerPolicy · BCBSM-2047285	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	GT-SOMATIC BIOMARKER TESTING FOR IMMUNE CHECKPOINT INHIBITOR THERAPY (BRAF, MSI/MMR, PD-L1, TMB)PayerPolicy · BCBSM-2183397	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	BONE MARROW TRANSPLANT - HEMATOPOIETIC CELL TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA - AUTOLOGOUS AND ALLOGENEICPayerPolicy · BCBSM-2026685	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	CIRCULATING TUMOR DNA AND CIRCULATING TUMOR CELLS FOR SELECTING TARGETED THERAPY FOR ADVANCED SOLID CANCERS (LIQUID BIOPSY)PayerPolicy · BCBSM-2002479	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	DRUG COATED BALLOON FOR URETHRAL STRICTURES (I.E., OPTILUME URETHRAL DRUG COATED BALLOON) - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2204978	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	GENETIC TESTING - NEXT GENERATION SEQUENCING FOR ASSESSMENT OF MEASURABLE RESIDUAL DISEASE (E.G, CLONOSEQ) IN HEMATOLOGICAL MALIGNANCIESPayerPolicy · BCBSM-2181828	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	GENETIC TESTING FOR CARDIAC ION CHANNELOPATHIES (E.G., CONGENITAL LONG QT SYNDROME, BRUGADA SYDROME, ETC.)PayerPolicy · BCBSM-2001707	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	GENETIC TESTING FOR LYNCH SYNDROME AND OTHER INHERITED COLON CANCER SYNDROMES (EFFECTIVE 07/01/2026)PayerPolicy · BCBSM-2209374-F4002587D8	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	BONE TURNOVER MARKERS FOR DIAGNOSIS AND MANAGEMENT OF OSTEOPOROSIS AND DISEASES ASSOCIATED WITH HIGH BONE TURNOVER - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2192446	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	GENETIC TESTING FOR THE DIAGNOSIS AND MANAGEMENT OF PANCREATIC CYSTS, AND SOLID PANCREATICOBILIARY LESIONS (E.G., PATHFINDER TG, PANCRAGEN)PayerPolicy · BCBSM-2002382	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	SKIN ADVANCED GLYCATION END PRODUCTS (AGE) MEASUREMENT BY MULTI-WAVELENGTH FLUORESCENT SPECTROSCOPY - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2194713	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	CONTINUOUS SUBCUTANEOUS INSULIN INFUSION (CSII) (INSULIN PUMPS) AND TRANSDERMAL INSULIN DELIVERY SYSTEMS - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2197259	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	MONOCHROMATIC INFRARED ENERGY (MIRE) DEVICE FOR THE TREATMENT OF CUTANEOUS ULCERS, DIABETIC NEUROPATHY AND MISCELLANEOUS MUSCULOSKELETAL CONDITIONSPayerPolicy · BCBSM-82722	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	BONE MARROW TRANSPLANT HEMATOPOIETIC CELL TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROMES AND MYELOPROLIFERATIVE NEOPLASMS, ALLOGENEIC - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2195972	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	BMT - HEMATOPOIETIC CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA AND BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM (BPDCN)PayerPolicy · BCBSM-2027400	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	GERMLINE GENETIC TESTING FOR GENE VARIANTS ASSOCIATED WITH BREAST CANCER IN INDIVIDUALS AT HIGH BREAST CANCER RISKPayerPolicy · BCBSM-2185397	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	CIRCULATING TUMOR DNA FOR MANAGEMENT OF NON-SMALL-CELL LUNG CANCER (LIQUID BIOPSY) - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2198908	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	LABORATORY TESTS POST TRANSPLANT (KIDNEY, HEART, AND LUNG) AND FOR HEART FAILURE (EFFECTIVE 09/01/2026)PayerPolicy · BCBSM-2210516-1AB65D2F68	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	IN-OFFICE NEEDLE ARTHROSCOPY (E.G., MI-EYE 2, MI-EYE 3 NEEDLESCOPE WITH CANNULA, AND VISIONSCOPE¿)PayerPolicy · BCBSM-2117564	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	GENETIC TESTING-BRAF/NTRK MUTATION IN SELECTING MELANOMA PATIENTS FOR TARGETED THERAPY INCLUDING LIQUID BIOPSYPayerPolicy · BCBSM-2097766	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	ORTHOPEDIC APPLICATIONS OF STEM-CELL THERAPY (INCLUDING ALLOGRAFTS AND BONE SUBSTITUTES USED WITH AUTOLOGOUS BONE MARROW)PayerPolicy · BCBSM-2026114	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	LIGHT AND LASER THERAPY FOR VITILIGO AND ECZEMA (INCLUDING FRAGILE XE SYNDROME) (EFFECTIVE 09/01/2026)PayerPolicy · BCBSM-2210509-4F57AFA1F1	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	INTERFERON LAMBDA 3 (IFNL3) TESTING TO PREDICT RESPONSE TO TREATMENT OF HEPATITIS C VIRUS (HCV) INFECTIONPayerPolicy · BCBSM-2095741	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	GROWING RODS FOR SCOLIOSIS (E.G., MAGEC SPINAL BRACING AND DISTRACTION SYSTEM) (EFFECTIVE 07/01/2026)PayerPolicy · BCBSM-2209376-52473931AB	New policy